<<<<<<< HEAD
% Created 2018-08-22 Wed 12:25
=======
% Created 2018-08-22 Wed 21:11
% Intended LaTeX compiler: pdflatex
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\documentclass[presentation, smaller]{beamer}
\usepackage[utf8]{inputenc}
\usepackage[T1]{fontenc}
\usepackage{fixltx2e}
\usepackage{graphicx}
\usepackage{grffile}
\usepackage{longtable}
\usepackage{wrapfig}
\usepackage{rotating}
\usepackage[normalem]{ulem}
\usepackage{amsmath}
\usepackage{textcomp}
\usepackage{amssymb}
\usepackage{capt-of}
\usepackage{hyperref}
\hypersetup{colorlinks,linkcolor=gray,urlcolor=blue}
\usepackage{textpos}
\usepackage{textgreek}
\usepackage[version=4]{mhchem}
\usepackage{chemfig}
\usepackage{siunitx}
\usepackage{gensymb}
\usepackage[usenames,dvipsnames]{xcolor}
\usepackage[T1]{fontenc}
\usepackage{lmodern}
\usepackage{verbatim}
\usepackage{tikz}
\usetikzlibrary{shapes.geometric,arrows,decorations.pathmorphing,backgrounds,positioning,fit,petri}
\usetheme[height=20pt]{Boadilla}
\usecolortheme[RGB={170,160,80}]{{structure}}
\author{Matthew Henderson, PhD, FCACB}
\date{\today}
\title{Summary of "Sweat and sour: an update on classic galactosemia"}
\institute[NSO]{Newborn Screening Ontario}
\titlegraphic{\includegraphics[height=1cm,keepaspectratio]{../logos/NSO_logo.pdf}\includegraphics[height=1cm,keepaspectratio]{../logos/cheo-logo.png} \includegraphics[height=1cm,keepaspectratio]{../logos/UOlogoBW.eps}}
\hypersetup{
 pdfauthor={Matthew Henderson, PhD, FCACB},
 pdftitle={Summary of "Sweat and sour: an update on classic galactosemia"},
 pdfkeywords={},
 pdfsubject={},
 pdfcreator={Emacs 25.2.1 (Org mode 8.3.4)}, 
 pdflang={English}}
\begin{document}

\maketitle

\logo{\includegraphics[width=1cm,height=1cm,keepaspectratio]{../logos/NSO_logo_small.pdf}}

\vspace{220pt}
\beamertemplatenavigationsymbolsempty
\setbeamertemplate{caption}[numbered]
\setbeamerfont{caption}{size=\tiny}
% \addtobeamertemplate{frametitle}{}{%
% \begin{textblock*}{100mm}(.85\textwidth,-1cm)
% \includegraphics[height=1cm,width=2cm]{cat}
% \end{textblock*}}


\tikzstyle{chemical} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=none]
\tikzstyle{hardware} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=gray!30]
\tikzstyle{ms} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{msw} = [rectangle, rounded corners, text width=7em, minimum height=1em,text centered, draw=orange, fill=none]
\tikzstyle{label} = [rectangle,text width=8em, minimum height=1em, text centered, draw=none, fill=none]
\tikzstyle{hl} = [rectangle, rounded corners, text width=5em, minimum height=1em,text centered, draw=black, fill=red!30]
\tikzstyle{box} = [rectangle, rounded corners, text width=5em, minimum height=5em,text centered, draw=black, fill=none]
\tikzstyle{arrow} = [thick,->,>=stealth]
\tikzstyle{hl-arrow} = [ultra thick,->,>=stealth,draw=red]




<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline1}]{Classical galactosemia}
=======
\begin{frame}[label={sec:orga03d061}]{Classical galactosemia}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\begin{itemize}
\item Caused by deficient activity of galactose-1-phosphate uridylyltransferase
\item prevalence is 1:16,000-60,000 live births
\item autosomal recessive
\begin{itemize}
\item 336 mutations is the GALT gene described
\end{itemize}

\item presents in the neonatal period
\begin{itemize}
\item potentially lethal
\end{itemize}

\item Therapy is life long dietary galactose restriction
\begin{itemize}
\item does not prevent long-term complications
\end{itemize}
\end{itemize}
\end{frame}

<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline2}]{Galactose}
=======
\begin{frame}[label={sec:orgd1f45fb}]{Galactose}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\begin{itemize}
\item Functions
\begin{itemize}
\item energy source in pre-weaning infants
\item glycosylation
\end{itemize}
\end{itemize}
\end{frame}

<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline3}]{Galactose metabolism}
=======
\begin{frame}[label={sec:org53056ae}]{Galactose metabolism}
\begin{center}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\includegraphics[width=0.7\textwidth]{./figures/Fig1.png}
\end{frame}

<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline4}]{GALT Protein}
=======
\begin{frame}[label={sec:orgd09a685}]{GALT Protein}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\begin{itemize}
\item ubiquitous enzyme
\end{itemize}

\textbf{crystal structure}
\end{frame}

<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline5}]{GALT catalytic mechanism}
\textbf{mechanism}
\end{frame}

\begin{frame}[label={sec:orgheadline6}]{GALT gene}
=======
\begin{frame}[label={sec:orgab7a534}]{GALT catalytic mechanism}
\alert{mechanism}
\end{frame}

\begin{frame}[label={sec:org28d1686}]{GALT gene}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\begin{itemize}
\item 9p13, 11 exons, \textasciitilde{}4 kb
\item housekeeping
\end{itemize}
\begin{block}{c.563A>G, p.Q188R}
\begin{itemize}
\item \textasciitilde{}64\% of galactosemic alleles in caucasian pop
\item Irish Travellers 1:430
\item Non-functional variant: Destabilise UMP-GALT
\begin{itemize}
\item no residual RBC GALT activity
\end{itemize}
\end{itemize}
\end{block}

\begin{block}{c.855G>T, p.K285N}
\begin{itemize}
\item slavic origin?
\item no residual RBC GALT activity
\end{itemize}
\end{block}
\end{frame}

<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline7}]{Duarte and Los Angles variants}
=======
\begin{frame}[label={sec:org59e10e5}]{Duarte and Los Angles variants}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\begin{itemize}
\item Duarte - 50\% RBC GALT enzyme activity
\item LA - elevated RBC GALT enzyme activity
\item Same electrophoretic pattern, both p.N314D
\item D is in linkage disequilibrium w a 4bp promoter deletion
\item p.D314 is the ancestral allele
\item p.N314 arose early in human evolution
\end{itemize}
\end{frame}


<<<<<<< HEAD
\begin{frame}[label={sec:orgheadline8}]{Diagnosis}
\end{frame}
\begin{frame}[label={sec:orgheadline9}]{Long-term outcome}
\end{frame}

\begin{frame}[label={sec:orgheadline10}]{Therapy}
=======
\begin{frame}[label={sec:org3c84768}]{Biochemical Features}
\begin{itemize}
\item \(\uparrow\)  Galatactose
\item \(\uparrow\) Gal-1-p - pathogenic
\item \(\uparrow\)  galactitol - cataracts
\item \(\uparrow\) galactonate
\item \(\downarrow\) UPD-Gal - disordered glycosylation
\item \(\downarrow\) UPD-Glc
\end{itemize}
\end{frame}

\begin{frame}[label={sec:org31c5123}]{Acute Presentation}
\begin{itemize}
\item asymptomatic at birth
\item feeding leads to:
\begin{itemize}
\item poor weight gain, vomiting, diarrhea
\item hepatocellular damage, lethargy, and hypotonia
\end{itemize}
\item May progress to Gram negative sepsis, cataracts
\end{itemize}
\end{frame}

\begin{frame}[label={sec:orgd4285c2}]{Diagnosis}
\begin{itemize}
\item reducing substances in urine - not specific or sensitive
\item Gal-1-P, galactose, galactitol in blood or urine
\item RBC Gal-1-P - not specific
\item RBC GALT activity
\begin{itemize}
\item Classic galactosemia - undetectable or 1\% of controls
\end{itemize}

\item Excluded from NBS because it can be diagnosed clinically, and long term complications are not prevented by early treatment
\end{itemize}
\end{frame}

\begin{frame}[label={sec:org6a47a80}]{Therapy}
\begin{itemize}
\item life long dietary restriction of galactose.
\item endogenous synthesis
\end{itemize}
\end{frame}
\begin{frame}[label={sec:orge960939}]{Long-term outcome}
\begin{itemize}
\item Cognitive impairment
\item Bone health - dairy restriction
\item Ovarian insufficiency
\end{itemize}
>>>>>>> c27b6d164efa59cf75395e1dd25d421dc72e004b
\end{frame}
\end{document}
